Cell Surgical Network’s Technology
Cutting Edge Solutions
The Cell Surgical Network is at the forefront of regenerative medicine, utilizing cutting-edge adipose-derived stem cells for deployment and clinical research. Unlike early stem cell research, which involved controversial embryonic stem cells, our focus lies on non-embryonic adult mesenchymal stem cells and specifically those found in one’s adipose tissue (fat).
This shift in cell therapy worldwide is due to the ease of obtaining and the robust nature of adipose-derived cells. Adipose fat serves as a plentiful and reliable source of stem cells, with 500-2000 times more stem cells in it than bone marrow. Further, the cells in adipose tissue are actually quite young relatively, regardless of one’s age.
The average lifespan of adipose is 7-10 years, meaning the stem cells within adipose are not required to multiply a divide frequently, keeping them young, healthy, potent, and viable.
Get Your Free Download Today
Enter your email below, and we’ll send you our download straight to your inbox!
Our Process
1
Meet & Greet
You have made an important decision to have a stem cell deployment.
2
Local Anesthesia & Harvesting Fat
Patients have their fat harvested in our special sterile treatment procedure under a local anesthetic
3
Preparation
After harvesting, stem cells are separated from fat cells. CSN’s process yields a high number of stem cells
4
Deployment
Stem cells are then injected into veins, arteries, spinal fluid, or directly into joints or bones.
The small amount of liposuctioned fat that is used is obtained in a virtually painless procedure done completely under local anesthesia, taking approximately 20 minutes.
Next, adipose-derived stem cells and stromal vascular fraction (SVF) are most easily and safely obtained through enzymatic isolation, which utilizes a GMP collagenase enzyme to break down the collagen matrix that binds the adipocytes to the remaining regenerative cells desired in SVF.
This technique, which used to require high-quality surgical technician skill, is now automated and prioritizes the total cell count and viability of the final SVF.
Once these adipose-derived stem cells are reintroduced into the patient, they have the potential to repair human tissue by promoting healing through cell signaling (paracrine effect) and generating new cells.
With their ability to form multiple cell and tissue types along with their ability to generate new blood vessels, adipose-derived stem cells show great promise in healing degenerative diseases and injuries.